Agenda

*Schedule is tentative and is subject to change.

Cellular Therapies and Novel Blood Products in Trauma and Critical Care – The Future of Transfusion Medicine

Wednesday, December 11 | Barriers in Translation for Novel Products in Trauma and Critical Care

Discussion and talks will focus upon funding, translation, cell product production and processing

11:00 am - 5:00 pm
Registration Open – Aragon Ballroom Foyer

Badge and Materials Pickup

2:30 pm - 2:35 pm
Welcome & Introductions
  • Shibani Pati MD, PhD

    CTTACC Conference Chair
    Professor of Laboratory Medicine, UCSF
    Scientific Director of Cellular Therapies

2:35 pm - 3:20 pm

Session 1 | Sustainability of Research and Successful Translation of Novel Therapeutics in Trauma and Critical Care: from Bench to Bedside and Beyond

Discussion will focus upon funding support for the translational pipeline which includes the infrastructure needed for pre-clinical and clinical trials in trauma and critical care. Funding from federal sources, industry, philanthropy and venture capital will be discussed. Panelists will include representation from the NIH, BARDA, DOD, industry stakeholders and a venture capital firm.

Moderator(s)
  • Raymond Goodrich PhD

    Executive Director, Infectious Disease Research Center
    Office of the Vice President for Research
    Professor, Department of Microbiology, Immunology and Pathology,
    Colorado State University

Panelists
  • Geoffrey Ling MD, PhD

    COL, USA, Ret.
    Chief Executive Officer at SunQ, LLC
    Ex Director and Founder of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office

  • Jim Sergi

    President of CSSi LifeSciences

  • Keith Hoots MD

    Director, Division of Blood Diseases and Resources
    National Heart, Lung, and Blood Institute

  • Mary Homer PhD

    Chief United States Radiological and Nuclear Countermeasures, Division of Chemical, Biological, Radiological, and Nuclear Countermeasures
    Biomedical Advanced Research and Development Authority (BARDA)

  • Michael Davis MD, FACS

    Col, USAF
    Director of the US Army Medical Research and Materiel Command’s Combat Casualty Care Research Program (CCCRP)

  • Terry Opgenorth PhD

    Vice President & Director of Launchpad
    Colorado State University Ventures

3:20 pm - 5:00 pm

Session 2 | Challenges in Product Development, Cell Production and Processing

Discussion will focus upon the translational barriers and challenges that exist in cell product production, development and processing. Panelists will include representation from the private industry, blood banks, NIH and academic centers involved in this space.

3:21 pm - 3:40 pm
Analysis of Stem Cell Heterogeneity to Identify Potency Markers
  • Dave Stroncek MD

    Director for Center for Cellular Engineering, NIH Clinical Center

3:40 pm - 4:00 pm
Challenges of Clinical Cell Product Production in an Academic Center: Manufacturing Autologous Regulatory T Cell Products
  • Jonathan Esensten MD, PhD

    Medical Director, UCSF HICTF and GMP Facility
    Medical Director, Zuckerberg San Francisco General Hospital Blood Bank and Transfusion Service
    Assistant Adjunct Professor, UCSF, Dept. of Laboratory Medicine

4:00 pm - 5:00 pm
Panel Discussion on Product Development, Processing and Production
Moderator(s)
  • Kenneth Bertram MD, PhD

    Co-Chair CTTACC
    COL, USA, Ret.
    Professor of Regenerative Medicine
    Wake Forest University

Panelists
  • Becky Cap

    Sr. Vice President, Chief Operating Officer, GenCure

  • Fabio Triolo D.d.R., M.Phil., PhD

    Associate Professor of Clinical and Translational Sciences
    Director, Cellular Therapy Core
    Department of Pediatric Surgery
    McGovern Medical School at UTHealth

  • Jon Rowley PhD

    Chief Executive & Technology Officer, RoosterBio, Inc.

  • Julie Allickson PhD

    Director, Regenerative Medicine Clinical Center
    Wake Forest University School of Medicine

  • Priya Baraniak PhD

    Vice President, Corporate Development
    OrganaBio, LLC

  • Robert Mays PhD

    Vice President, Regenerative Medicine
    Head of Neurosciences, Athersys, Inc.

5:00 pm - 5:50 pm

Session 3 | Optimizing Cell Product Development and Delivery to Patients

Discussion will focus upon the current successes and challenges that exist in finalizing the end of product development which includes optimal cryopreservation, storage, shipping, handling and delivery of the final product to patients. These are areas that are critical for the success and safety of the products, clinical trials and final patient outcomes. Panelists will include representation from the private industry, blood banks and academic centers involved in this space.

Moderator(s)
  • Aby J. Mathew PhD

    Senior VP & CTO
    BioLife Solutions

  • Shibani Pati MD, PhD

    CTTACC Conference Chair
    Professor of Laboratory Medicine, UCSF
    Scientific Director of Cellular Therapies

Panelists
  • Bob Harman DVM, MPVM

    Chief Scientific Officer & Co-Founder of Personalized Stem Cells, Inc.

  • Charles Cox MD

    The George and Cynthia Mitchell Distinguished Chair in Neurosciences
    Director, Children’s Program in Regenerative Medicine
    Professor, Department of Pediatric Surgery
    McGovern Medical School at UTHealth

  • Christopher Murphy

    M SGT, USA, Ret.
    CEO Combat Medical Solutions

  • David McKenna MD

    Professor of Transfusion Medicine
    Director of the Division of Transfusion Medicine
    University of Minnesota

  • Donna Chang

    President & CEO
    Hope Biosciences

  • Fabio Triolo D.d.R., M.Phil., PhD

    Associate Professor of Clinical and Translational Sciences
    Director, Cellular Therapy Core
    Department of Pediatric Surgery
    McGovern Medical School at UTHealth

6:00 pm - 6:50 pm
Reception – Buena Vista Terrace
6:50 pm - 7:00 pm
Introduction of Keynote Speaker – Santiago Courtyard 
  • John Holcomb MD, FACS

    Co-Chair CTTACC
    COL, USA, Ret.
    Professor of Surgery
    University of Alabama at Birmingham

7:00 pm - 7:30 pm
2019 Keynote | The Power of Yes
  • Geoffrey Ling MD, PhD

    COL, USA, Ret.
    Chief Executive Officer at SunQ, LLC
    Ex Director and Founder of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office

7:30 pm - 9:00 pm
Dinner – Santiago Courtyard

Thursday, December 12 | Transfusion Medicine in Trauma and Critical Care

The goal of this session is to discuss and understand pertinent issues in transfusion medicine and novel blood products related to the bleeding and acutely injured trauma patient. Topics of discussion will focus around novel blood products and adjuncts to resuscitation in bleeding patients.

7:00 am - 8:00 am
Breakfast | Aragon Lawn
7:00 am - 5:00 pm
Registration Area Open – Aragon Ballroom Foyer

Badge and Materials Pickup

8:00 am - 8:05 am
Welcome & Introduction
  • Shibani Pati MD, PhD

    CTTACC Conference Chair
    Professor of Laboratory Medicine, UCSF
    Scientific Director of Cellular Therapies

Session 1 | Whole Blood – The First Cell Therapy in Trauma

Moderator(s)
  • Paul Ness MD

    Senior Director, Division of Transfusion Medicine
    Professor of Pathology
    Johns Hopkins University

  • Philip Spinella MD, FCCM

    Professor of Pediatrics
    Washington Univ School of Medicine St. Louis

8:05 am - 8:20 am
Civilian Whole Blood Use: The Portland, OR Experience
  • Martin Schreiber MD

    CTTACC Conference Co-Chair
    COL, USAR
    Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
    Oregon Health & Science University (OHSU)

8:20 am - 8:35 am
Military Whole Blood Use
  • Stacy Shackleford MD

    Col, USAF MC
    Joint Trauma System, Chief
    DHA Combat Support

8:35 am - 8:50 am
Civilian Whole Blood Use: The Pittsburgh, PA Experience
  • Jason Sperry MD, MPH

    Professor of Surgery and Critical Care
    Director of Acute Care Surgery Fellowship
    University of Pittsburgh

8:50 am - 9:05 am
Southwest Texas Regional Advisory Council for Trauma Pre-hospital Whole Blood Resuscitation Program
  • Donald Jenkins MD

    COL, USAF, Ret.
    Professor of Surgery Uniformed Services University
    Professor/Clinical, Division of Trauma and Emergency Surgery
    Vice Chair for Quality, Department of Surgery UT San Antonio
    Betty and Bob Kelso Distinguished Chair in Burn and Trauma Surgery

9:05 am - 9:20 am
Question & Answer Panel | Session 1
9:20 am - 9:40 am
Coffee Break – Aragon Ballroom Foyer

Visit Exhibits

Session 2 | Novel Resuscitation Adjuncts and Blood Products in Trauma

Moderator(s)
  • Matthew Neal MD

    Roberta G. Simmons Assistant Professor of Surgery
    Assistant Professor of Clinical and Translational Science and Critical Care Medicine
    University of Pittsburgh

  • Richard Weiskopf MD

    Professor Emeritus
    University of California, San Francisco

9:40 am - 9:55 am
Resuscitation Adjuncts in Trauma
  • Hasan Alam MD

    Norman W. Thompson Professor of Surgery
    Section Head of General Surgery
    University of Michigan

9:55 am - 10:10 am
COMBAT vs. PAMPER Prehospital Plasma First Resuscitation : Impact of Transport Time
  • Ernest Moore MD

    Professor of Surgery
    Vice Chair of Research
    Editor of Journal of Trauma and Acute Care Surgery

10:10 am - 10:25 am
Tranxanemic Acid as a Resuscitative Adjunct for Treatment of TBI
  • Martin Schreiber MD

    CTTACC Conference Co-Chair
    COL, USAR
    Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
    Oregon Health & Science University (OHSU)

10:25 am - 10:40 am
Endothelial and Mitochondrial Effects of TXA
  • Joseph Rappold MD

    Co-Chair CTTACC
    CAPT, USN, Ret.
    Professor of Surgery
    Maine Medical Center Tufts University

10:40 am - 10:55 am
Precision Approaches to Trauma Resuscitation – The TACTIC Trial
  • Karim Brohi MD

    Professor of Trauma Sciences
    Queen Mary University of London
    Director London Major Trauma System

10:55 am - 11:10 am
Question & Answer Panel | Session 2
11:10 am - 12:00 pm
Discussion Panel on Challenges in the Development, Study and Implementation of Pre-hospital Interventions
Moderator(s)
  • John Holcomb MD, FACS

    Co-Chair CTTACC
    COL, USA, Ret.
    Professor of Surgery
    University of Alabama at Birmingham

  • Martin Schreiber MD

    CTTACC Conference Co-Chair
    COL, USAR
    Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
    Oregon Health & Science University (OHSU)

Panelists
  • Andrew (Andre) Cap MD, PhD

    COL, USA
    Professor of Medicine
    Uniformed Services University of the Health Sciences
    Chief, Blood Research Program
    US Army Institute for Surgical Research

  • Beth Shaz MD

    President AABB
    Chief Medical and Scientific Officer
    Senior Vice President at New York Blood Center

  • Christophe Martinaud MD

    Professor of Transfusion Medicine and Cell Therapy
    French Military Blood Institute Clamart

  • Ernest Moore MD

    Professor of Surgery
    Vice Chair of Research
    Editor of Journal of Trauma and Acute Care Surgery

  • Jason Sperry MD, MPH

    Professor of Surgery and Critical Care
    Director of Acute Care Surgery Fellowship
    University of Pittsburgh

  • Karim Brohi MD

    Professor of Trauma Sciences
    Queen Mary University of London
    Director London Major Trauma System

12:00 pm - 1:00 pm
Lunch – Aragon Lawn

Visit Exhibits

Session 3 | Dried Plasma, Artificial RBCs and Pathogen Reduction of Blood

Moderator(s)
  • Jeffrey McCullough MD

    Emeritus Professor,
    University of Minnesota

  • Richard Weiskopf MD

    Professor Emeritus
    University of California, San Francisco

1:00 pm - 1:15 pm
Alternative uses for Pathogen-Reduced Plasma: It’s not all about the clot
  • Rosemary Kozar MD, PhD

    Professor of Surgery
    Director of Translational Research Shock Trauma
    University of Maryland School of Medicine, R Adams Cowley Shock Trauma Center

1:15 pm - 1:30 pm
Pathogen Reduction in Transfusion Safety of Novel Blood Products
  • Larry Corash MD

    Senior VP and Chief Scientific Officer Cerus Inc.

1:30 pm - 1:45 pm
Encapsulated HBOCs to Artificial & Engineered Red Cells: Update and Preclinical Results
  • Allan Doctor MD

    Professor of Pediatrics, Biochemistry and Bioengineering
    Director, Center for Blood Oxygen Transport and Hemostasis
    University of Maryland School of Medicine

1:45 pm - 2:00 pm
Blood Banks Providing Novel and Alternative Blood Products
  • Beth Shaz MD

    President AABB
    Chief Medical and Scientific Officer
    Senior Vice President at New York Blood Center

2:00 pm - 2:15 pm
Question & Answer Panel | Session 3
2:15 pm - 2:35 pm
Coffee Break – Aragon Ballroom Foyer

Visit Exhibits

Session 4 | Novel Platelet and Platelet Derived Products

Moderator(s)
  • Heather Pidcoke MD, PhD

    Chief Medical Research Officer
    Associate Director, Research
    Translational Medicine Institute
    Colorado State University

  • Lucy Kornblith MD

    Assistant Professor of Surgery
    Trauma Surgery and Surgical Critical Care
    University of California San Francisco
    Zuckerberg San Francisco General Hospital

2:35 pm - 2:50 pm
Freeze Dried Platelets in Trauma Related Applications- Pre-clinical to Clinical Translation
  • Mike Fitzpatrick PhD

    COL, USA, Ret.
    President & Director of Research and Development, Cellphire Inc.

2:50 pm - 3:05 pm
Platelets and Platelet Dysfunction in Trauma
  • Karim Brohi MD

    Professor of Trauma Sciences
    Queen Mary University of London
    Director London Major Trauma System

3:05 pm - 3:20 pm
Cold Stored Platelets in Trauma – The Optimal Product for Military and Civilian Use
  • Andrew (Andre) Cap MD, PhD

    COL, USA
    Professor of Medicine
    Uniformed Services University of the Health Sciences
    Chief, Blood Research Program
    US Army Institute for Surgical Research

3:20 pm - 3:35 pm
Platelet Biology and Cytoskeletal Mechanics
  • Owen McCarty PhD

    Professor and Chair of Department of Biomedical Engineering
    Professor of Department of Cell & Development Biology
    Oregon Health & Science University

3:35 pm - 3:50 pm
Regulation of Vascular Stability by 4C Platelets: Are circulating numbers critical measures of function?
  • Shibani Pati MD, PhD

    CTTACC Conference Chair
    Professor of Laboratory Medicine, UCSF
    Scientific Director of Cellular Therapies

3:50 pm - 4:05 pm
Freeze Dried Platelets in Treating Traumatic Brain Injury
  • Alpa Mahuvakar Trivedi PhD

    Research Professor
    Department of Laboratory Medicine, UCSF

4:05 pm - 4:20 pm
Question & Answer Panel | Session 4

Session 5 | Product Development, Support and Regulatory Approval of Novel Blood Products

Discussion will focus upon the current successes, challenges and translational barriers that exist in the development of novel blood products.

Moderator(s)
  • Victor Macdonald PhD

    SME Blood Products
    USAMRMC

4:20 pm - 4:40 pm
Priorities for Military Medicine and Research
  • Michael Davis MD, FACS

    Col, USAF
    Director of the US Army Medical Research and Materiel Command’s Combat Casualty Care Research Program (CCCRP)

4:40 pm - 5:00 pm
Mission of BARDA in Novel Blood Product Development
  • Erika Davies PhD

    Health Scientist
    Division of Chemical, Biological, Radiological, and Nuclear Countermeasures (DBRN)
    Biomedical Advanced Research and Development Authority (BARDA)

5:00 pm - 5:45 pm
Discussion Panel: Novel Blood Product Development in Transfusion Medicine

Discussion will focus upon the current successes, challenges and translational barriers that exist in the development of novel blood products. Including dried plasma, dried platelets, dried cryoprecipitate, and more.

Moderator(s)
  • Kenneth Bertram MD, PhD

    Co-Chair CTTACC
    COL, USA, Ret.
    Professor of Regenerative Medicine
    Wake Forest University

  • Richard Gonzales MS, MT(ASCP)SBB

    COL, USA, Ret.
    President and CEO
    Richblo2d Biologics Consulting Services LLC

Panelists
  • Andrew (Andre) Cap MD, PhD

    COL, USA
    Professor of Medicine
    Uniformed Services University of the Health Sciences
    Chief, Blood Research Program
    US Army Institute for Surgical Research

  • Larry Corash MD

    Senior VP and Chief Scientific Officer Cerus Inc.

  • Mark Popovsky MD

    Chief Medical Officer
    Velico Medical, Inc

  • Mike Fitzpatrick PhD

    COL, USA, Ret.
    President & Director of Research and Development, Cellphire Inc.

  • Peter Marks MD, PhD

    Director, Center for Biologics Evaluation and Research
    U.S. Food and Drug Administration

  • Zafiris Zafirelis

    Chief Executive Officer, Hemoglobin Oxygen Therapeutics LLC

6:00 pm - 7:00 pm
Reception – Aragon Terrace
7:00 pm - 9:00 pm
Dinner – Aragon Lawn

Friday, December 13 | Cellular Therapies in Trauma and Critical Care Medicine

The goal of this session is to discuss and learn about the state of the science of cellular therapies in trauma and critical care. Pre-clinical and clinical studies will be presented in traumatic brain injury (TBI), Spinal Cord Injury (SCI), acute respiratory distress syndrome (ARDS), acute kidney injury (AKI), cardiac disease, wound healing and tissue and bone regeneration.

7:00 am - 8:00 am
Breakfast – Aragon Lawn
7:00 am - 1:00 pm
Registration Area Open – Aragon Ballroom Foyer

Badge and Materials Pickup

8:00 am - 8:30 am
Plenary Talk | A Success Story in Cellular Therapies: Allogeneic CAR-T Cell Therapy

Session 1 | Cellular Therapies in Critical Care Medicine

Moderator(s)
  • Charles Cox MD

    The George and Cynthia Mitchell Distinguished Chair in Neurosciences
    Director, Children’s Program in Regenerative Medicine
    Professor, Department of Pediatric Surgery
    McGovern Medical School at UTHealth

  • Lauralyn McIntyre MD

    Associate Professor in the Department of Medicine, University of Ottawa
    Senior Scientist with the Clinical Epidemiology Department of the Ottawa Hospital Research Institute

8:30 am - 8:50 am
Stem Cells and Genomics for Precision Cardiovascular Medicine
  • Joseph C. Wu MD, PhD

    Director, Stanford Cardiovascular Institute Simon H. Stertzer, MD
    Professor of Medicine & Radiology Stanford University School of Medicine

8:50 am - 9:10 am
Regenerative Medicine Advances in Healthcare
  • Anthony Atala MD

    Professor of Surgery
    Chair, Department of Urology
    Director, Wake Forest Institute for Regenerative Medicine at Wake Forest University

9:10 am - 9:30 am
Cellular Therapies in ARDS – Pre-clinial to Clinical Trials
  • Michael Matthay MD

    Professor of Pulmonary Critical Care Medicine
    Associate Director of ICU
    University of California San Francisco

9:30 am - 9:50 am
Inflammatory Lung Environment Effects on MSC Behaviors
  • Daniel Weiss MD, PhD

    Professor of Medicine
    University of Vermont
    ISCT Chief Scientific Officer

9:50 am - 10:10 am
Multipotent Adult Progenitor Cells in ARDS
  • Robert Mays PhD

    Vice President, Regenerative Medicine
    Head of Neurosciences, Athersys, Inc.

10:10 am - 10:25 am
Question & Answer Panel | Session 1
10:25 am - 10:45 am
Coffee Break – Aragon Ballroom Foyer

Visit Exhibits

Session 2 | Cellular Therapies in Neurotrauma and Organ Regeneration

Moderator(s)
  • Deborah Stein MD

    Professor and Chief of Surgery
    Zuckerberg San Francisco General,
    Vice Chair of Trauma and Critical Care Surgery
    UCSF Department of Surgery

  • Hasan Alam MD

    Norman W. Thompson Professor of Surgery
    Section Head of General Surgery
    University of Michigan

10:45 am - 11:05 am
Adult and Pediatric Clinical Trials of HSCs and MAPCs in Traumatic Brain Injury (TBI)
  • Charles Cox MD

    The George and Cynthia Mitchell Distinguished Chair in Neurosciences
    Director, Children’s Program in Regenerative Medicine
    Professor, Department of Pediatric Surgery
    McGovern Medical School at UTHealth

11:05 am - 11:25 am
Human Neural Stem Cell Grafts for Repair of Spinal Cord Injury
  • Ephron Rosenzweig PhD

    Assistant Professor of Neurosciences
    Center for Neural Repair
    University of California San Diego

11:25 am - 11:45 am
Human Clinical Trial of Neural Progenitor Cells in SCI
  • Joseph Ciacci MD

    Professor of Neurosurgery
    Vice Chair of Research
    University of California San Diego

11:45 am - 12:00 pm
Question & Answer Panel | Session 2
12:00 pm - 12:25 pm
Featured Presentation | FDA’s Role in Facilitating the Development of Cellular Therapies
  • Peter Marks MD, PhD

    Director, Center for Biologics Evaluation and Research
    U.S. Food and Drug Administration

12:30 pm - 1:30 pm
Lunch – Aragon Lawn

Visit Exhibits

Session 3 | Cellular Therapies for Wound Healing, Bone Healing and Burns

Moderator(s)
  • Jan Nolta PhD

    Director, Stem Cell Program and Institute for Regenerative Cures
    University of California Davis Health
    Scientific Director, UC Davis GMP Facility
    Editor-in-Chief, Stem Cells

  • Samuel P. Carmichael II MD

    Acute Care Surgery Fellow
    Wake Forest Baptist Medical Center

1:30 pm - 1:50 pm
Innate Immunity in Injury
  • Clifford Lowell MD, PhD

    Professor and Distinguished Chairman Department of Laboratory Medicine, UCSF

1:50 pm - 2:10 pm
Stem Cells in Wound Healing & Tissue Repair
  • Jan Nolta PhD

    Director, Stem Cell Program and Institute for Regenerative Cures
    University of California Davis Health
    Scientific Director, UC Davis GMP Facility
    Editor-in-Chief, Stem Cells

2:10 pm - 2:30 pm
Pluripotent Stem Cells for Skeletal Regeneration and the Hematopoietic Niche
  • Joy Wu MD

    Assistant Professor of Medicine
    Co Director Translational Investigator Program
    Stanford University

2:30 pm - 2:50 pm
French Military Clinical Experience with MSCs in Thermal and Radiation Burn Injury
  • Christophe Martinaud MD

    Professor of Transfusion Medicine and Cell Therapy
    French Military Blood Institute Clamart

2:50 pm - 3:10 pm
Question & Answer Panel | Session 3
3:10 pm - 3:25 pm
Break – Aragon Ballroom Foyer

Visit Exhibits

Session 4 | New Technologies, Regulatory Issues and Challenges in the Field

Moderator(s)
  • Michael Matthay MD

    Professor of Pulmonary Critical Care Medicine
    Associate Director of ICU
    University of California San Francisco

3:25 pm - 3:45 pm
Development of a Donor-Independent Platelet-Like Cellular Therapy
  • Tom Schulz PhD

    VP of Manufacturing Sciences, Platelet BioGenesis

3:45 pm - 4:05 pm
The Cell Therapy Translational Pipeline from Bench to Bedside with New Emerging Technologies: Perspectives on CAR-T cells and IPSC derived Cells and Tissue
  • Jürgen Schmitz PhD

    Chief Scientific Officer
    Miltenyi Biotec

4:05 pm - 4:25 pm
Ex Vivo Mesenchymal Stromal Cell Therapy for the Treatment of Systemic Inflammatory Disease
  • Biju Parekkadan PhD

    Associate Professor, Biomedical Engineering, Rutgers University
    Division Leader, Center for Surgery, Innovation, and Bioengineering, Harvard Medical School and Massachusetts General Hospital
    Affiliated Faculty, Harvard Stem Cell Institute and the Broad Institute for Genetics
    Co-Founder, Director, and Office of Chief Scientific Officer, Sentien Biotechnologies, Inc.

4:25 pm - 4:30 pm
Concluding Remarks
  • Martin Schreiber MD

    CTTACC Conference Co-Chair
    COL, USAR
    Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
    Oregon Health & Science University (OHSU)

  • Shibani Pati MD, PhD

    CTTACC Conference Chair
    Professor of Laboratory Medicine, UCSF
    Scientific Director of Cellular Therapies

4:30 pm - 5:30 pm
Closing Cocktail Reception

Presented by the University of California San Francisco Department of Laboratory Medicine

SIGNUP FOR MORE INFORMATION

Questions? Email us at info@cttacc.org or call 303-238-0685